Literature DB >> 28499926

Epigenetic Studies of Perinatal Determinants of Later Obesity Link Important, but Previously Unrelated, Genetic and Epidemiological Findings.

Shelley A Cole1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28499926      PMCID： PMC5478202          DOI： 10.1016/j.ebiom.2017.05.004

Source DB:  PubMed          Journal:  EBioMedicine        ISSN： 2352-3964            Impact factor:   8.143


× No keyword cloud information.
  3 in total

Review 1.  Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?

Authors:  Sarah Anissa Hannou; Kristiaan Wouters; Réjane Paumelle; Bart Staels
Journal:  Trends Endocrinol Metab       Date:  2015-03-03       Impact factor: 12.015

2.  Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales.

Authors:  D J Barker; C Osmond
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

3.  ANRIL Promoter DNA Methylation: A Perinatal Marker for Later Adiposity.

Authors:  Karen Lillycrop; Robert Murray; Clara Cheong; Ai Ling Teh; Rebecca Clarke-Harris; Sheila Barton; Paula Costello; Emma Garratt; Eloise Cook; Philip Titcombe; Bhuvaneshwari Shunmuganathan; Samantha J Liew; Yong-Cai Chua; Xinyi Lin; Yonghui Wu; Graham C Burdge; Cyrus Cooper; Hazel M Inskip; Neerja Karnani; James C Hopkins; Caroline E Childs; Carolina Paras Chavez; Philip C Calder; Fabian Yap; Yung Seng Lee; Yap Seng Chong; Philip E Melton; Lawrie Beilin; Rae-Chi Huang; Peter D Gluckman; Nick Harvey; Mark A Hanson; Joanna D Holbrook; Keith M Godfrey
Journal:  EBioMedicine       Date:  2017-04-26       Impact factor: 8.143
  3 in total
  1 in total

1.  INSIG2 rs7566605 single nucleotide variant and global DNA methylation index levels are associated with weight loss in a personalized weight reduction program.

Authors:  Francesca Pirini; Sebastian Rodriguez-Torres; Bola Grace Ayandibu; María Orera-Clemente; Alberto Gonzalez-de la Vega; Fahcina Lawson; Roland J Thorpe; David Sidransky; Rafael Guerrero-Preston
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.